https://www.premera.com/medicalpolicies/1.01.525.pdf#search=policy
MEDICAL POLICY - 1.01.525 Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis BCBSA Ref. Policy: 1.01.28 Effective Date: June 1, 2022 Last ...
https://www.premera.com/medicalpolicies/2.02.506.pdf#search=policy
MEDICAL POLICY - 2.02.506 Wearable Cardioverter-Defibrillators as a Bridge to Implantable Cardioverter-Defibrillator Placement BCBSA Ref. Policy: 2.02.15, 7.01.44 Effective Date: ...
https://www.premera.com/medicalpolicies/2.04.516.pdf#search=policy
MEDICAL POLICY - 2.04.516 Measurement of Serum Antibodies to Selected Biologic Agents BCBSA Ref. Policy: 2.04.84 Effective Date: Feb. 1, 2023 Last Revised: Jan. 9, 2023 Replaces: ...
https://www.premera.com/medicalpolicies/5.01.532.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.532 Cutaneous T-Cell Lymphomas (CTCL): Systemic ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/5.01.568.pdf#search=policy
PHARMACY POLICY - 5.01.568 Venclexta® (venetoclax) BCL-2 Inhibitor Effective Date: Dec. ... POLICY CRITERIA | CODING | RELATED INFORMATION EVIDENCE REVIEW | REFERENCES | HISTORY ∞ ...
https://www.premera.com/medicalpolicies/5.01.576.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.576 Drugs for Rare Diseases Effective Date: Mar. 1, 2023 ... POLICY CRITERIA | CODING | RELATED INFORMATION EVIDENCE REVIEW | REFERENCES | APPENDIX | ...
https://www.premera.com/medicalpolicies/5.01.593.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.593 Pharmacologic Treatment of Transthyretin-Mediated Amyloidosis BCBSA Ref. Policy: 5.01.30 Effective Date: Feb. 1, 2023 Last Revised: Jan. 10, ...
https://www.premera.com/medicalpolicies/5.01.596.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.596 Pharmacologic Treatment of Osteoporosis Effective ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.608.pdf#search=policy
MEDICAL POLICY - 5.01.608 Pharmacologic Treatment of Postpartum Depression Effective ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.609.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.609 Spravato® (esketamine) Nasal Spray Effective Date: ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.623.pdf#search=policy
PHARMACY POLICY - 5.01.623 Topical Drugs for Actinic Keratosis and Other Dermatologic ... below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ...
https://www.premera.com/medicalpolicies/5.01.628.pdf#search=policy
PHARMACY / MEDICAL POLICY - 5.01.628 Pharmacologic Treatment of Atopic Dermatitis ... POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE ...
https://www.premera.com/medicalpolicies/7.01.101.pdf#search=policy
MEDICAL POLICY - 7.01.101 Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome BCBSA Ref. Policy: 7.01.101 Effective Date: Sept. 1, 2022 Last Revised: Aug. 8, 2022 ...
https://www.premera.com/medicalpolicies/7.01.154.pdf#search=policy
MEDICAL POLICY - 7.01.154 Ablation of Peripheral Nerves to Treat Pain BCBSA Ref. Policy: 7.01.154 Effective Date: Dec. 1, 2022 Last Revised: Nov. 7, 2022 Replaces: 7.01.565 ...
https://www.premera.com/medicalpolicies/7.01.165.pdf#search=policy
MEDICAL POLICY - 7.01.165 Radiofrequency Coblation Tenotomy for Musculoskeletal Conditions BCBSA Ref. Policy: 7.01.165 Effective Date: Mar. 1, 2022 Last Revised: Feb. 7, 2022 ...
https://www.premera.com/medicalpolicies/8.01.63.pdf#search=policy
MEDICAL POLICY - 8.01.63 Chimeric Antigen Receptor Therapy for Leukemia and Lymphoma BCBSA Ref. Policy: 8.01.63 Effective Date: Dec. 1, 2022 Last Revised: Nov. 8, 2022 Replaces: ...
https://www.premera.com/medicalpolicies/8.01.66.pdf#search=policy
MEDICAL POLICY - 8.01.66 Chimeric Antigen Receptor Therapy for Multiple Myeloma BCBSA Ref. Policy: 8.01.66 Effective Date: Oct. 1, 2022 Last Revised: Sept. 13, 2022 Replaces: N/A ...
https://www.premera.com/medicalpolicies/1.01.10.pdf#search=policy
MEDICAL POLICY - 1.01.10 Continuous Passive Motion in the Home Setting BCBSA Ref. Policy: 1.01.10 Effective Date: June 1, 2022 Last Revised: May 9, 2022 Replaces: N/A RELATED ...
https://www.premera.com/medicalpolicies/1.01.11.pdf#search=policy
MEDICAL POLICY - 1.01.11 Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynostoses BCBSA Ref Policy: 1.01.11 Effective Date: June 1, 2022 Last Revised: May 9, ...
https://www.premera.com/medicalpolicies/1.01.15.pdf#search=policy
MEDICAL POLICY - 1.01.15 Oscillatory Devices for the Treatment of Cystic Fibrosis and Other Respiratory Conditions BCBSA Ref. Policy: 1.01.15 Effective Date: Sept. 1, 2022 Last ...